Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria

International Journal of Clinical Pharmacology and Therapeutics

Volumn 37, Issue 1, 1999, Pages 58-61

  Pham, Y T ^a   Nosten, F ^b,c,d   Farinotti, R ^a   White, N J ^c,d   Gimenez, F ^a,e  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Autopsy; Brain; Mefloquine; Pharmacokinetics; Stereoisomers; Stereoselectivity

Indexed keywords

MEFLOQUINE;

ADULT; ARTICLE; BRAIN MALARIA; CASE REPORT; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISPOSITION; DRUG PENETRATION; DRUG UPTAKE; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; ORAL DRUG ADMINISTRATION; RACEMIC MIXTURE; WHITE MATTER;

AUTOPSY; BRAIN; FATAL OUTCOME; FEMALE; HUMANS; MALARIA, CEREBRAL; MALE; MEFLOQUINE; STEREOISOMERISM;

EID: 0032896317     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bem JL, Kerr L, Stuerchler D 1992 Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. J Trop Med Hyg 95: 167-179
2. Gimenez F, Dumartin C, Wainer IW, Farinotti R 1993 Improved column-switching liquid Chromatographic method for the determination of the enantiomers of mefloquine. J Chromatogr 619: 161-166
3. Gimenez F, Pennie RA, Koren G, Crevoisier C, Wainer IW, Farinotti K 1994 Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses. J Pharm Sci 83: 824-827
4. Hellgren U, Jastrebova J, Jerling M, Krysén B, Bergqvist Y 1996 Comparison between concentrations of racemic mefloquine, its separate enantiomers and the carboxylic acid metabolite in whole blood serum and plasma. Eur J Clin Pharmacol 51: 171-173
5. Jones R, Kunsman G, Levine B, Smith M, Stahl C 1994 Mefloquine distribution in post mortem cases. Forensic Sci Int 68: 29-32
6. Luxemburger C, Nosten F, Ter Kuile F, Frejacques L, Chongsuphajaisiddhi T, White NJ 1991 Mefloquine for multidrug-resistant malaria. Lancet 338: 1268
7. Mu JY, Israili H, Dayton PG 1975 Studies of the disposition and metabolism of mefloquine HCl (WR 142, 490). A quinoline methanol antimalarial, in the rat. Drug Metab Dispos 3: 198-210
8. Nguyen TH, Day NP, Ly VC 1996 Post malaria neurological syndrome. Lancet 348: 917-921
9. Phillips-Howard PA, Ter Kuile F 1995 CNS adverse events associated with antiimalarial agents. Fact or fiction? Drug Saf 12: 370-380
10. Rapoport TS, Ohno K, Pettigrew D 1979 Drug entry into the brain. Brain Res 172: 354-359
11. Riffkin CD, Chung R, Wall DM, Zalcberg JR, Cowman AF, Foley M, Tilley L 1996 Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine. Biochem Pharmacol 52: 1545-1552
12. Rouveix B, Bricaire F, Michon C 1989 Mefloquine and acute brain syndrome. Ann Int Med 110: 577-578
13. Sowunmi A, Salako LA, Oduola AM, Walker O, Akindele JA, Ogundahunsi OA 1983 Neuropsychiatric side effects of mefloquine in Africans. Trans R Soc Trop Med Hyg 87: 462-463
14. Stuiver PC, Lightelm RJ, Goud LM 1989 Acute psychosis after mefloquine. Lancet 2: 28
15. Ter Kuile F 1994 Serious neuro-psychiatric adverse events following mefloquine treatment: evidence for a dose relationship. In: Ter Kuile F (ed): Mefloquine, Halofantrine and Artesunate in the Treatment of Uncomplicated Falciparum Malaria in a Multidrug-Resistant Area. PhD Thesis Amsterdam University, Amsterdam, pp 173-182
16. Van Bree JBM, De Boer AG, Danhof M, Breimer D 1992 Drug transport across the blood brain barrier. Pharmaceutish Weekblad Scientific Edition 14: 305-310
17. Weinke T, Trautmann M, Held T 1991 Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg 45: 86-91